
%201.webp)



%201.webp)





LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


%201.webp)



%201.webp)





序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

在埃塞俄比亚,埃塞俄比亚食品和药物管理局(EFDA)在确保药品的安全性、有效性和质量方面发挥着关键作用。其监管框架的核心是EFDA可追溯性指令,这是一套全面的要求,旨在增强药品供应链中药品的可追溯性。

EFDA要求对药品进行序列化,要求每个单位都带有唯一的标识符。这种序列化可以实现精确的跟踪和追踪,确保药品在供应链中流动时的真实性和完整性。
药品制造商必须在供应链的各个阶段向EFDA提交详细数据。这包括有关生产、分销和销售的信息。强大的数据报告和整合框架使EFDA能够有效监控药品的流动,并迅速应对任何违规行为。
EFDA通过检查和审计实施严格的合规监督。制药实体必须接受定期评估,以确保遵守序列化和数据报告要求。违规行为可能会导致处罚,包括罚款和监管行动。
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.


要了解 EFDA 可追溯性指令的错综复杂,需要采取战略性和经验丰富的方法。我们的专业团队为寻求实施和维护强大的可追溯系统的制药实体提供量身定制的解决方案。从序列化策略到数据集成,我们指导组织实现合规,在埃塞俄比亚建立透明、安全的药品供应链。

由于埃塞俄比亚强调药品可追溯性是公共卫生的关键方面,因此与EFDA追溯指令保持一致不仅是一项监管要求,而且是对确保民众福祉的承诺。与我们合作,了解EFDA的可追溯性要求,确保您在埃塞俄比亚制药领域扮演负责任和合规的参与者的角色。立即联系我们,踏上通往药物诚信和卓越监管的旅程。




We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.
Pharmaceutical products in Ethiopia are regulated by the Ethiopian Food and Drug Authority (EFDA) under the Food and Medicine Administration Proclamation No. 1112/2019. Ethiopia has introduced regulatory requirements to improve medicine traceability and combat counterfeit pharmaceutical products.
The EFDA requires pharmaceutical manufacturers and importers to implement serialization using GS1 compliant DataMatrix barcodes on medicine packaging. The system enables verification of medicines and supports supply chain monitoring from manufacturers and importers through distribution.
The Ethiopian traceability framework is designed to align with global GS1 identification standards and supports electronic verification of medicines throughout the supply chain. Serialization requirements apply primarily to human prescription medicines and selected priority pharmaceutical products.
Medicines marketed in Ethiopia must include a 2D DataMatrix barcode on the secondary packaging to support serialization and traceability.
The DataMatrix must follow GS1 standards and include the following data elements:
These elements enable unique identification of each pharmaceutical package and support product verification within the Ethiopian supply chain.
Human readable information printed on the packaging must match the encoded barcode data.
2011–2017
Ethiopia introduced regulatory initiatives aimed at improving pharmaceutical supply chain integrity and combating counterfeit medicines.
2019
The Ethiopian government adopted Proclamation No. 1112/2019, strengthening the authority of EFDA to regulate medicines and medical products.
2020 onward
EFDA began implementing serialization initiatives and encouraging pharmaceutical manufacturers to adopt GS1 based DataMatrix identification for medicine packages.
Current Status
Serialization requirements are being progressively adopted to improve product verification and supply chain oversight.
Companies must maintain accurate traceability records and provide them to EFDA during regulatory inspections when required.
| Operation | Data to Report | When to Report |
Commission | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
ReceivingImport Clearance Supply to Pharmacy | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
Returns Decommission | Serial status and reference Reason and serials | When return is approved When product is destroyed or removed |
Ethiopia’s pharmaceutical traceability system is overseen by the Ethiopian Food and Drug Authority (EFDA).
The system supports verification of serialized products through digital identification and authentication mechanisms. Pharmaceutical manufacturers and importers must ensure that serialized identifiers are generated according to EFDA requirements and maintained within their internal traceability systems.
While the EFDA regulates serialization requirements, supply chain reporting primarily relies on company traceability systems and regulatory inspections, rather than a centralized national reporting platform.
Ethiopia’s serialization framework focuses on unit level identification using DataMatrix barcodes.
Aggregation at case or pallet level is not currently mandated in EFDA guidance. Pharmaceutical companies may implement aggregation internally to improve logistics and warehouse management.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.